Articles about NanoString

Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process

NanoString announced Wednesday that it will be acquired by Bruker, ending the company’s restructuring process that included a Chapter 11… Read More

Healthcare investment firm Patient Square Capital agrees to acquire NanoString assets for $220M

NanoString, the Seattle-based biotech company that initiated a Chapter 11 bankruptcy process last month, announced late Sunday it agreed to… Read More

NanoString stock sinks 70% as Seattle biotech company enters bankruptcy process

Seattle-based publicly traded biotech company NanoString Technologies announced Monday that it has initiated a Chapter 11 bankruptcy plan and is exploring… Read More

NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq

Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions,… Read More

NanoString stock sinks nearly 50% after losing patent lawsuit case against 10x Genomics

Shares of Seattle-based publicly traded biotech company NanoString Technologies fell nearly 50% to an all-time low on Monday following its… Read More

Tech Moves: Esper names CFO; Streem founder steps down; Nanostring adds board member

— David Barclay, former chief financial officer for DigniFi and Xevo, joined Esper as CFO. Esper is a Seattle-based startup… Read More

Tech Moves: Life Science Washington names new CEO; AWS exec departs; Vizio CTO retires

— Life Science Washington announced Marc Cummings as its new CEO and president. He was most recently the trade association’s… Read More

Tech Moves: Accolade names chief medical officer; Apptio hires marketing lead; Rigado has a new CEO

— Health technology company Accolade landed Dr. Shantanu Nundy as chief medical officer. Nundy formerly worked on digital health initiatives… Read More

Tech Moves: Algorithmia lands former Atlassian and InfluxData execs; GitHub hires former Google Cloud leader

Rachel Potvin signed on with Microsoft-owned GitHub as vice president of engineering. Potvin most recently led the data insights group… Read More

Here are the winners and (mostly) losers of Seattle tech stocks in 2018

Whew! Stocks were all over the place in 2018. Things were going well in late summer, but by fall the… Read More

Tech Moves: Amazon hires top doc; Geir Hansen leaves SVB; Acumatica board adds ex-Microsoft Business Solutions chief

Amazon is continuing to bolster its health care game. The company recently hired Dr. Martin Levine, a longtime Seattle doctor… Read More

Biotechnology company NanoString partners with Merck to create test for anti-cancer drug

NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to… Read More

NanoString Technologies misses estimates as losses deepen

NanoString Technologies, a Seattle-based biotech company focused on developing cancer treatments, faced deepening losses this quarter as the company missed… Read More

The best and worst performing tech stocks of 2014 in the Seattle area

It was a busy year for publicly-traded tech companies in the Seattle region, with plenty of winners and losers. The… Read More

NanoString expands office and lab space

NanoString, a 12-year-old Seattle company whose tools help genetic researchers better analyze genes and molecules, is expanding its footprint in… Read More

NanoString chief medical officer J. Wayne Cowens passes away at the age of 67

Dr. J. Wayne Cowens, the chief medical officer at Seattle-based NanoString Technologies, has died at the age of 67. “We… Read More

Nanostring posts record revenue of $10.9M, up 51% from last year

NanoString Technologies, a provider of life science tools for research and molecular diagnostic products, beat Wall Street’s expectations with a record… Read More

NanoString files for $55M stock offering, expects 37% revenue growth for 2013

NanoString Technologies, a provider of life science tools for research and molecular diagnostic products, has filed to raise $55 million… Read More

Nanostring IPO disappoints as shares fall 20% on first day

It was a tough first day on the stock market for Seattle’s NanoString Technologies, with shares falling 19.4 percent on Wednesday as… Read More

NanoString sets IPO range of $13-$15, plans to trade on Nasdaq under ticker NSTG

Seattle’s NanoString Technologies today set the terms for its upcoming initial public offering, with plans to sell shares in the… Read More

NanoString lands $15.3M for genetic analysis system

NanoString Technologies continues to rake in new capital, announcing today that it has raised $15.3 million from Morgan Stanley Expansion Capital… Read More

Tech Moves: Andy Sack passes torch at Lighter Capital; OUYA’s new hire

Andy Sack is stepping aside as CEO of Lighter Capital, the Seattle investment firm that provides revenue-based loans to companies… Read More

Tech Moves: GameHouse taps Keela Robison; NanoString hires biotech vet Bruce Seely

Keela Robison is returning to her roots. After stints at Amazon.com and WhitePages, Robison is returning to RealNetworks’ and its… Read More

NanoString lands $20 million

NanoString Technologies, a maker of genomic analysis tools, has raised $20 million in venture capital financing in a deal led… Read More